Dapagliflozin USP Related Compound A

N° de SZ CAT:	SZ-D015001
Número CAS	1807632-95-6
Mol.F.	C21H25BrO6
Peso Molecular	453.3
Status de Fatura	In Stock

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

Nome Químico: (2S,3R,4R,5S,6R)-2-[4-Bromo-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (as per USP)

Sinônimo: Dapagliflozin 4-Bromo Analog ; Dapagliflozin Impurity-S3C (Bromo Dapagliflozin)

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

Sorrisos: O[C@H]1[C@H](C2=CC(CC3=CC=C(OCC)C=C3)=C(Br)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1O

Stability indicating rp-hplc method for simultaneous estimation of dapagliflozin and saxagliptin in pharmaceutical dosage forms
By Thota, Hanisha; Soundarya, G.
From Journal of Global Trends in Pharmaceutical Sciences (2021), 12(1), 9131-9137

Method development and validation of a stability-indicating reversed-phase liquid chromatographic method for the simultaneous estimation of metformin and dapagliflozin in presence of their degradation products
By Kotecha, Nidhi; Patel, Jayvadan
From International Journal of Pharmaceutical Sciences Review and Research (2019), 56(2), 1-6.

Validation of a newly developed stability indicating RP-liquid chromatographic method for the quantitative determination of dapagliflozin
By Sura, Sreenivasulu; Modalavalasa, Rameswara Rao; Kothapalli, ChandraSekhar B.
From Pharma Chemica (2018), 10(1), 93-102

Dapagliflozin USP Related Compound A is chemically (2S,3R,4R,5S,6R)-2-[4-Bromo-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (as per USP). It is also known as Dapagliflozin 4-Bromo Analog ; Dapagliflozin Impurity-S3C (Bromo Dapagliflozin). Dapagliflozin USP Related Compound A is supplied with detailed characterization data compliant with regulatory guideline. Dapagliflozin USP Related Compound A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dapagliflozin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

products.relatedproducts